bluebird bio, Inc. Operating Lease, Expense
bluebird bio, Inc. reported Operating Lease, Expense of $58.60 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-03-29
- bluebird bio, Inc. operating lease, expense for fiscal 2022 was $58.60M, a 61.88% increase from fiscal 2021.
- bluebird bio, Inc. operating lease, expense for fiscal 2021 was $36.20M, a 49.59% increase from fiscal 2020.
- bluebird bio, Inc. operating lease, expense for fiscal 2020 was $24.20M, a 3.86% increase from fiscal 2019.
- bluebird bio, Inc. operating lease, expense for fiscal 2019 was $23.30M.
| Period end | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|
| 2022-12-31 | $58.60M 10-K · filed 2023-03-29 | |
| 2021-12-31 | $36.20M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $24.20M 10-K · filed 2023-03-29 | $47.70M 10-K · filed 2021-02-23 |
| 2019-12-31 | $23.30M 10-K · filed 2022-03-04 | $45.30M 10-K · filed 2020-02-18 |